Volume 40, Issue 4

Search all International Journal of Clinical Pharmacy articles

August 2018

Special Issue on Pharmacovigilance

Filter by

Volume:

Sort by

Date published:

New to old Old to new

29 articles in this issue

Overview of this issue: pharmacovigilance, what is new?
Linda Gore Martin
Yolande Hanssens
Vibhu Paudyal
Editorial 21 August 2018 Pages: 737 - 739
The role and strategy of ISoP in global pharmacovigilance
Sten Olsson
Mira Harrison-Woolrych
Commentary 02 August 2018 Pages: 740 - 743
An historical overview over Pharmacovigilance
Giulia Fornasier
Sara Francescon
Paolo Baldo
Commentary Open access 15 June 2018 Pages: 744 - 747
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Paolo Baldo
Sara Francescon
Giulia Fornasier
Commentary Open access 09 August 2018 Pages: 748 - 753
Current trends in pharmacovigilance: value and gaps of patient reporting
Pedro Inácio
Afonso Cavaco
Marja Airaksinen
Commentary 13 July 2018 Pages: 754 - 757
Pharmacovigilance in developing countries (part I): importance and challenges
Shaimaa Elshafie
Iman Zaghloul
Anne Marie Roberti
Commentary 16 December 2017 Pages: 758 - 763
Pharmacovigilance in developing countries (part II): a path forward
Shaimaa Elshafie
Anne Marie Roberti
Iman Zaghloul
Commentary 10 January 2018 Pages: 764 - 768
Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar
Moza Al Hail
Wessam Elkassem
Derek Stewart
Commentary 03 April 2018 Pages: 769 - 774
The role of the suspicious renal pharmacist in identifying unusual adverse drug reactions—why this is not a small problem
Carolyn Vera Coulter
Commentary 01 June 2018 Pages: 775 - 777
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
Sara Francescon
Giulia Fornasier
Paolo Baldo
Commentary Open access 09 August 2018 Pages: 778 - 782
Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance
Angela Lupattelli
Olav Spigset
Hedvig Nordeng
Commentary Open access 15 June 2018 Pages: 783 - 786
Is pharmacovigilance of biologicals cost-effective?
Barbara Claus
Commentary 26 July 2018 Pages: 787 - 789
Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension
Marie-Camille Chaumais
Caroline O’Connell
David Montani
Commentary 13 August 2018 Pages: 790 - 794
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
G. Fornasier
M. Taborelli
P. Baldo
Research Article Open access 21 May 2018 Pages: 795 - 802
Finasteride use during pregnancy and early neonatal outcome: a case report
Doua AlSaad
Ben H. Lee
Sawsan Al-Obaidly
Commentary 01 June 2018 Pages: 803 - 805
Potential negative impact of informing patients about medication side effects: a systematic review
Jimmy Jose
Lamia AlHajri
Review Article 23 August 2018 Pages: 806 - 822
Pharmacovigilance in China: development and challenges
Ying Zhao
Tiansheng Wang
Shusen Sun
Review Article 26 July 2018 Pages: 823 - 831
Pharmacovigilance in oncology
Paolo Baldo
Giulia Fornasier
Sara Francescon
Review Article Open access 01 August 2018 Pages: 832 - 841
Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals
Anna Laven
Katharina Schmitz
Wilhelm-Hubertus Franzen
Research Article 16 June 2018 Pages: 842 - 851
Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma
João P. Aguiar
Fábio Cardoso Borges
Filipa Alves da Costa
Research Article 02 June 2018 Pages: 852 - 861
Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database
Ying Zhao
Haidong Lu
Tiansheng Wang
Research Article 20 February 2018 Pages: 862 - 869
Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population
Sara Modig
Sölve Elmståhl
Research Article Open access 19 February 2018 Pages: 870 - 877
Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
Raymond Li
Colin Curtain
Syed Tabish Razi Zaidi
Research Article Open access 10 August 2018 Pages: 878 - 889
Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy
Geoffrey C. Wall
Matthew J. Taylor
Hayden L. Smith
Research Article 14 March 2018 Pages: 890 - 894
Healthcare professionals’ knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia
Mohammed Assen Seid
Asmamaw Emagn Kasahun
Saron Naji Gebremariam
Research Article 09 August 2018 Pages: 895 - 902
Comparison of different methods for causality assessment of adverse drug reactions
Sapan Kumar Behera
Saibal Das
Selvarajan Sandhiya
Research Article 26 July 2018 Pages: 903 - 910
Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone
Jun-Hong Ye
Yunn-Fang Ho
Yun-Wen Tang
Research Article 26 July 2018 Pages: 911 - 920
Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database
Xiaotong Li
Sydney Thai
Tiansheng Wang
Research Article 26 July 2018 Pages: 921 - 927
Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study
Luis Hermenegildo Martin Arias
Antonio Martin Gonzalez
Maria Sainz
Research Article 31 July 2018 Pages: 928 - 935

Volume 40, Issue 4

Search

Navigation